Report of the roundtable discussion organised by the Swiss Proteomics Society (SPS), Bern, 8th December 2004.
How close are we to using proteomics tools in the every day practice of physicians? What are the socio-economical issues our health care system may face with the advent of biomarkers for early diagnosis? How to get the specialists from the various disciplines integrated in proteomics to establish a common understanding of the clinical issues and develop the necessary standards (methods, biochemicals and IT)? These were the kind of questions a panel of specialists tried to answer during the roundtable discussion that took place in Bern during the Swiss Proteomics Society 2004 congress.
Noukakis
Dimitrios
D
N!light, Marketing and Communication in Life Sciences, Préverenges, Switzerland.
Gadola
Stephan
S
Stöcklin
Reto
R
D001331:Automation; D015415:Biomarkers / Q000378:metabolism; D019295:Computational Biology; D005820:Genetic Testing; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods; D040901:Proteomics / Q000379:methods* / Q000639:trends; D012923:Social Class; D013557:Switzerland
D015415:Biomarkers